Cargando…
Deregulation of kinase signaling and lymphoid development in EBF1-PDGFRB ALL leukemogenesis
The chimeric fusion oncogene EBF1-PDGFRB is a recurrent lesion observed in Ph-like B-ALL and is associated with particularly poor prognosis. While it is understood that this fusion activates tyrosine kinase signaling, the mechanisms of transformation and importance of perturbation of EBF1 activity r...
Autores principales: | Welsh, Seth J., Churchman, Michelle L., Togni, Marco, Mullighan, Charles G., Hagman, James |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5709252/ https://www.ncbi.nlm.nih.gov/pubmed/28555080 http://dx.doi.org/10.1038/leu.2017.166 |
Ejemplares similares
-
The EBF1-PDGFRB T681I mutation is highly resistant to imatinib and dasatinib in vitro and detectable in clinical samples prior to treatment
por: Tran, Thai Hoa, et al.
Publicado: (2021) -
Evidence for PDGFRA, PDGFRB and KIT deregulation in an NSCLC patient
por: Negri, T, et al.
Publicado: (2007) -
伴EBF1-PDGFRB融合基因阳性急性淋巴细胞白血病2例报告并文献复习
Publicado: (2023) -
Unusual PDGFRB fusion reveals novel mechanism of kinase activation in Ph-like B-ALL
por: Sadras, Teresa, et al.
Publicado: (2023) -
伴EBF1-PDGFRB融合基因的Ph样急性B淋巴细胞白血病一例报告并文献复习
Publicado: (2016)